Waldencast (NASDAQ:WALD) Sets New 12-Month Low at $4.71

Waldencast plc (NASDAQ:WALD) shares hit a new 52-week low on Wednesday . The stock traded as low as $4.71 and last traded at $4.71, with a volume of 11555 shares. The stock had previously closed at $4.89.

Analyst Ratings Changes

Separately, Telsey Advisory Group decreased their price target on Waldencast from $10.00 to $8.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 1st.

Waldencast Price Performance

The firm’s fifty day simple moving average is $6.22 and its 200-day simple moving average is $8.02.

Institutional Trading of Waldencast

Large investors have recently made changes to their positions in the stock. Zeno Equity Partners LLP acquired a new stake in shares of Waldencast during the fourth quarter worth $224,278,000. Truxt Investmentos Ltda. grew its holdings in Waldencast by 3.7% in the 4th quarter. Truxt Investmentos Ltda. now owns 4,075,479 shares of the company’s stock valued at $44,586,000 after buying an additional 144,841 shares during the period. Bank of New York Mellon Corp grew its holdings in Waldencast by 73.6% in the 3rd quarter. Bank of New York Mellon Corp now owns 86,409 shares of the company’s stock valued at $814,000 after buying an additional 36,642 shares during the period. Simplicity Wealth LLC acquired a new position in shares of Waldencast during the 1st quarter valued at about $142,000. Finally, Bleakley Financial Group LLC purchased a new position in shares of Waldencast during the 1st quarter worth about $142,000. Institutional investors and hedge funds own 41.97% of the company’s stock.

About Waldencast

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.